Glucocorticoids are a class of anti-inflammatory drugs commonly used to treat various ocular
and systemic conditions. Although the role of glucocorticoids in the treatment of numerous …

Atopic dermatitis (AD) is the long-lasting chronic inflammatory skin condition associated with
cutaneous hyper-reactivity and triggered by environmental factors. The attributes of AD …

This guideline was developed as a joint interdisciplinary European project, including
physicians from all relevant disciplines as well as patients. It is a consensus‐based …

Background Ocular comorbidities are common in atopic dermatitis (AD) as the result of the
disease itself or the use of medication. No large-scale epidemiologic data exist on the …

Glucocorticoids are widely used as an ophthalmic medication. A common, sight-threatening
adverse event of glucocorticoid usage is ocular hypertension, caused by dysfunction of the …

Atopic eczema is a chronic inflammatory disease affecting about 30% of A ustralian and N
ew Z ealand children. Severe eczema costs over AUD 6000/year per child in direct medical …

Glaucoma is extensively treated with topical eye drops containing drugs. However, the
retention time of the loaded drugs and the in vivo bioavailability of the drugs are highly …

A cataract is a condition that causes 17 million people to experience blindness and is the
most significant cause of vision loss, around 47.9%. The formation of cataracts is linked to …

Tofacitinib is an inhibitor of Janus kinases (JAK), which is approved to manage moderate to
severe conditions of rheumatoid arthritis, showing inadequate response or intolerance to …

The projected number of people who will develop age-related macular degeneration in
estimated at 2020 is 196 million and is expected to reach 288 million in 2040. Also, the …